Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             62 results found
no title author magazine year volume issue page(s) type
1 American Association for Cancer Research Annual Meeting 2016 Coburn, Cassandra
2016
17 6 p. 707-708
article
2 Analysis of prognosis in CLL: collaboration makes the difference van Oers, Marinus H J
2016
17 6 p. 691-692
article
3 An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data 2016
17 6 p. 779-790
article
4 Antibody–drug conjugates for cancer therapy Thomas, Anish
2016
17 6 p. e254-e262
article
5 Australia tax increases to price cigarettes out of reach Kirby, Tony
2016
17 6 p. e228
article
6 Bortezomib improves survival in rare myeloma Brower, Vicki
2016
17 6 p. e227
article
7 Cachexia in patients with cancer Jafri, Syed H
2016
17 6 p. e220-e221
article
8 Cachexia in patients with cancer Williams, Grant R
2016
17 6 p. e220
article
9 Cancer care in Bali Kenyon, Georgina
2016
17 6 p. 710-712
article
10 Cancer in the aftermath of Nepal's earthquakes Mishra, Shiva Raj
2016
17 6 p. 705-706
article
11 Cancer-related Wernicke-Korsakoff syndrome Sechi, GianPietro
2016
17 6 p. e221-e222
article
12 Can short-term hormone therapy for rising PSA prolong survival? D'Amico, Anthony V
2016
17 6 p. 687-688
article
13 Charities raise alarm over changes to UK Cancer Drugs Fund Burki, Talha Khan
2016
17 6 p. e230
article
14 Complete lymph node dissection in melanoma Ariyan, Charlotte
2016
17 6 p. 688-689
article
15 Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial Leiter, Ulrike
2016
17 6 p. 757-767
article
16 Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus Schmiegelow, Kjeld
2016
17 6 p. e231-e239
article
17 Correction to Lancet Oncol 2015; 16: 522 2016
17 6 p. e223
article
18 Correction to Lancet Oncol 2016; 17: 751 2016
17 6 p. e223
article
19 Correction to Lancet Oncol 2016; 17: 553 2016
17 6 p. e223
article
20 Correction to Lancet Oncol 2016; 17: 733 2016
17 6 p. e223
article
21 Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial Sartore-Bianchi, Andrea
2016
17 6 p. 738-746
article
22 Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial Vansteenkiste, Johan F
2016
17 6 p. 822-835
article
23 Encouraging results for PD-1 inhibition in gastric cancer Smyth, Elizabeth C
2016
17 6 p. 682-683
article
24 FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis Suker, Mustafa
2016
17 6 p. 801-810
article
25 Immediate androgen deprivation: for all or for some? Leapman, Michael S
2016
17 6 p. 683-684
article
26 Ixazomib for multiple myeloma Burki, Talha Khan
2016
17 6 p. e228
article
27 Joining forces for children with cancer in Latin America Gonzalez-Ramella, Oscar
2016
17 6 p. 701-703
article
28 Knots and cancer Ranscombe, Peter
2016
17 6 p. 713
article
29 Locally advanced pancreatic cancer: maybe not so local O'Dwyer, Peter J
2016
17 6 p. 694-695
article
30 Maggie's podcast Worley, Luke
2016
17 6 p. 714
article
31 New European guidance on patient-reported outcomes Venkatesan, Priya
2016
17 6 p. e226
article
32 New risk loci for endometrial cancer identified Burki, Talha Khan
2016
17 6 p. e229
article
33 NHS England misses cancer referral targets again Burki, Talha Khan
2016
17 6 p. e224
article
34 Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review Bentivegna, Enrica
2016
17 6 p. e240-e253
article
35 Pathological complete remission and long-term outcome—what do we know in 2016? Gnant, Michael
2016
17 6 p. 693-694
article
36 PD-1 inhibition in advanced Merkel-cell carcinoma Baker, Holly
2016
17 6 p. e225
article
37 Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial Muro, Kei
2016
17 6 p. 717-726
article
38 Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial Krop, Ian E
2016
17 6 p. 811-821
article
39 PI3K targeting in breast cancer: the end of the beginning? Bachelot, Thomas
2016
17 6 p. 696-697
article
40 Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial Bendixen, Morten
2016
17 6 p. 836-844
article
41 Post-operative survival of patients with lung cancer Quoix, Elisabeth
2016
17 6 p. 697-698
article
42 Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial Carrie, Christian
2016
17 6 p. 747-756
article
43 Severe sleep apnoea linked to melanoma risk Tanday, Sanjay
2016
17 6 p. e229
article
44 SNP affects colorectal cancer outcomes with cetuximab Brower, Vicki
2016
17 6 p. e230
article
45 Struggle, survival, and triumph: a comeback story Gourd, Katherine
2016
17 6 p. 716
article
46 Student's death highlights gaps in China's health regulations Ouyang, Yadan
2016
17 6 p. 709
article
47 Surveillance benefit for pancreatic cancer in high-risk individuals Baker, Holly
2016
17 6 p. e227
article
48 Targeting HER2: precision oncology for colorectal cancer Schmoll, Hans-Joachim
2016
17 6 p. 685-686
article
49 The added effect of depression on patients with cancer Gunjur, Ashray
2016
17 6 p. e225
article
50 The Cancer Survivor's Garden Companion Feetham, Nigel
2016
17 6 p. 714
article
51 The five Rs of chemotherapy Tannock, Ian F
2016
17 6 p. 703-705
article
52 The smaller the better: a new concept in thoracic surgery? Petrella, Francesco
2016
17 6 p. 699-700
article
53 Thyroid cancer subtype downgraded to non-cancer Tanday, Sanjay
2016
17 6 p. e224
article
54 Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial Duchesne, Gillian M
2016
17 6 p. 727-737
article
55 Training a new generation of surgical oncologists worldwide Balch, Charles M
2016
17 6 p. 700-701
article
56 Trastuzumab cardiotoxicity in early-stage breast cancer Burki, Talha Khan
2016
17 6 p. e226
article
57 Uniform definition of continuous-deep sedation Morita, Tatsuya
2016
17 6 p. e222
article
58 Venetoclax: a new weapon to treat high-risk CLL Rossi, Davide
2016
17 6 p. 690-691
article
59 Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study Stilgenbauer, Stephan
2016
17 6 p. 768-778
article
60 Virtual surgery Kirby, Tony
2016
17 6 p. 715
article
61 When is a carcinogen not a carcinogen? The Lancet Oncology,
2016
17 6 p. 681
article
62 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial Gianni, Luca
2016
17 6 p. 791-800
article
                             62 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands